US screening of ovarian masses: Cost-effectiveness evaluation

D. Paladini, A. Lamberti, A. Teodoro, A. Tartaglione, P. Martinelli, C. Nappi

Research output: Contribution to journalArticle

Abstract

The role of unselected population screening for epithelial ovarian cancer (EOC) represents one of the most discussed issued in Gynecologic Oncology. The progressive reduction of the gross national product allotted to financing health interventions during the last decades has increased the attention to NHSs to cost-effectiveness analyses. As far as EOC screening is concerned, all epidemiological data seem to indicate that this disease is not suitable for screening.

Original languageEnglish
JournalUltrasound in Medicine and Biology
Volume26
Issue numberSUPPL. 2
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'US screening of ovarian masses: Cost-effectiveness evaluation'. Together they form a unique fingerprint.

  • Cite this

    Paladini, D., Lamberti, A., Teodoro, A., Tartaglione, A., Martinelli, P., & Nappi, C. (2000). US screening of ovarian masses: Cost-effectiveness evaluation. Ultrasound in Medicine and Biology, 26(SUPPL. 2).